Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer. [electronic resource]
Producer: 20160929Description: 128-133 p. digitalISSN:- 1880-4233
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Chemotherapy, Adjuvant -- statistics & numerical data
- Cohort Studies
- Drug Costs
- Drug-Related Side Effects and Adverse Reactions
- Female
- Gonadotropin-Releasing Hormone -- agonists
- Humans
- Japan
- Lymph Nodes -- pathology
- Mastectomy
- Middle Aged
- Neoplasm Staging
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retrospective Studies
- Selective Estrogen Receptor Modulators -- therapeutic use
- Young Adult
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.